NYSE

ADC Therapeutics SA Common Shares (ADCT)

♥ 660 Thanks from members

Live price chart, market sentiment, and community perspectives for ADC Therapeutics SA Common Shares (NYSE: ADCT).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Resolute Venture Partners TeamLeadership: Peter Hug (CEO)Leadership: Joseph Camardo (CMO)Holder: Bruton CapitalHolder: Sectoral Asset ManagementHolder: Point72 Asset ManagementZynlonta (loncastuximab tesirine-lpyl)ADCT-601ADCT-701#ADCT#ADC Therapeutics#Biotech#Zynlonta#Oncology Stock